Transamerica Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Transamerica Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25M	Sell	4,279 -497	-10%	-$279K	0.19%	121
2026 Q1	$2.68M	Sell	4,776 -325	-6%	-$208K	0.23%	105
2025 Q4	$3.45M	Buy	+5,101	New	+$3.47M	0.29%	95
2025 Q2	–	Sell	-1	Closed	-$1K	–	577
2025 Q1	$1K	Hold	1	–	–	﹤0.01%	491
2024 Q4	$1K	Hold	1	–	–	﹤0.01%	484
2024 Q3	$1K	Hold	1	–	–	﹤0.01%	492
2024 Q2	$1K	Hold	1	–	–	﹤0.01%	460
2024 Q1	$1K	Hold	1	–	–	﹤0.01%	505
2023 Q4	$1K	Sell	1 -7	-88%	-$3.29K	﹤0.01%	487
2023 Q3	$4K	Hold	8	–	–	﹤0.01%	359
2023 Q2	$4K	Sell	8 -2	-20%	-$958	﹤0.01%	332
2023 Q1	$5K	Hold	10	–	–	﹤0.01%	332
2022 Q4	$5K	Sell	10 -2	-17%	-$776	﹤0.01%	339
2022 Q3	$4K	Hold	12	–	–	﹤0.01%	348
2022 Q2	$5K	Buy	+12	New	+$4.89K	﹤0.01%	337
2021 Q3	–	Sell	-3	Closed	-$2K	–	160
2021 Q2	$2K	Hold	3	–	–	0.05%	68
2021 Q1	$2K	Hold	3	–	–	0.05%	92
2020 Q4	$2K	Buy	+3	New	+$1.34K	0.04%	90
2020 Q3	–	Sell	-1	Closed	-$1K	–	319
2020 Q2	$1K	Hold	1	–	–	﹤0.01%	406
2020 Q1	$1K	Hold	1	–	–	0.02%	97
2019 Q4	$1K	Buy	+1	New	+$264	0.01%	103
2019 Q3	–	Sell	-1,317	Closed	-$363K	–	287
2019 Q2	$363K	Buy	+1,317	New	+$324K	0.08%	137
2019 Q1	–	Sell	-1,339	Closed	-$250K	–	258
2018 Q4	$250K	Buy	1,339 +183	+16%	+$37.5K	0.06%	145
2018 Q3	$289K	Sell	1,156 -20	-2%	-$4.86K	0.06%	159
2018 Q2	$257K	Buy	+1,176	New	+$242K	0.06%	166

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Transamerica Financial Advisors's IDXX Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its Idexx Laboratories (IDXX) stake by 10% in Q2 2026, selling an estimated $279K and leaving 4,279 shares worth $2.25M. The position accounts for 0.19% of the portfolio, ranked #121.

Transamerica Financial Advisors first reported a position in IDXX in Q2 2018 and has held it in 25 quarters since. The position peaked at $3.45M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Transamerica Financial Advisors held 4,279 shares of Idexx Laboratories worth $2.25M as of Q2 2026.
Transamerica Financial Advisors sold 497 Idexx Laboratories shares in Q2 2026, an estimated $279K.
Idexx Laboratories made up 0.19% of Transamerica Financial Advisors's portfolio in Q2 2026, its #121 holding.
Transamerica Financial Advisors first reported a position in Idexx Laboratories in Q2 2018 and has held it in 25 quarters since.
Transamerica Financial Advisors's Idexx Laboratories position peaked at $3.45M in Q4 2025.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.